Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets

PHASE3CompletedINTERVENTIONAL
Enrollment

526

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Asthma
Interventions
DRUG

montelukast (5mg QD)

DRUG

Salmeterol/Fluticasone propionate Inhalation Powder (50/100mcg BID)

Trial Locations (26)

1010

GSK Investigational Site, Caracas

1060

GSK Investigational Site, Caracas

1080

GSK Investigational Site, Caracas

1330

GSK Investigational Site, Adana

3000

GSK Investigational Site, Santa Fe

6100

GSK Investigational Site, Ankara

6720

GSK Investigational Site, México

7070

GSK Investigational Site, Antalya

14080

GSK Investigational Site, Mexico City

16059

GSK Investigational Site, Bursa

31020

GSK Investigational Site, Chihuahua City

34303

GSK Investigational Site, Istanbul

34668

GSK Investigational Site, Istanbul

35100

GSK Investigational Site, Izmir

44340

GSK Investigational Site, Guadalajara

64460

GSK Investigational Site, Monterrey

11001000

GSK Investigational Site, Bogotá

76001000

GSK Investigational Site, Santiago de Cali

C1121ABE

GSK Investigational Site, Buenos Aires

C1424BSF

GSK Investigational Site, Capital Federal-Buenos Aires

05001000

GSK Investigational Site, Medellín

Unknown

GSK Investigational Site, San José

03020

GSK Investigational Site, Mexico City

04530

GSK Investigational Site, México

Lima 1

GSK Investigational Site, Lima

Lima 27

GSK Investigational Site, Lima

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY